Globus Medical (GMED) FCF Margin (2011 - 2026)
Globus Medical's (GMED) quarterly FCF Margin came in at 22.36% in Q2 2026, up 1816.0% on a YoY basis from 1.17% in Q2 2025, and up 4.41% quarter-over-quarter from 21.42% in Q1 2026.
Powered by 
Analysis
Globus Medical (GMED) FCF Margin (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has reported FCF Margin for 16 consecutive years, with 22.36% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin rose 1816.0% year-over-year to 22.36%; the trailing twelve-month figure through Jun 2026 stood at 24.03% (up 394.0% YoY), and the FY2025 full-year result was 20.03%, up 395.0% from the prior year.
- FCF Margin advanced to 22.36% in Q2 2026 per GMED's latest filing, from 21.42% in the prior quarter.
- Across five years, FCF Margin topped out at 29.4% in Q4 2024 and bottomed at 3.93% in Q1 2024.
- Historically, FCF Margin has averaged 14.89% across 5 years, with a median of 13.38% in 2023.
- The sharpest annual moves came in 2022 and 2025: FCF Margin plunged 1765 bps in 2022, then jumped 1968 bps in 2025.
- Over 5 years, FCF Margin stood at 16.62% in 2022, then fell by 20 bps to 13.27% in 2023, then soared by 122 bps to 29.4% in 2024, then slipped by 17 bps to 24.49% in 2025, then retreated by 9 bps to 22.36% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 22.36%, 21.42%, and 24.49% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.73% |
| 10 | Globus Medical | 9.94 Bn | 9.35 Bn | 548.17 Mn | 22.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.36% |
| Mar 31, 2026 | 21.42% |
| Dec 31, 2025 | 24.49% |
| Sep 30, 2025 | 27.81% |
| Jun 30, 2025 | 4.20% |
| Mar 31, 2025 | 23.61% |
| Dec 31, 2024 | 29.40% |
| Sep 30, 2024 | 25.84% |
| Jun 30, 2024 | 4.20% |
| Mar 31, 2024 | 3.93% |
| Dec 31, 2023 | 13.27% |
| Sep 30, 2023 | 7.55% |
| Jun 30, 2023 | 5.88% |
| Mar 31, 2023 | 13.49% |
| Dec 31, 2022 | 16.62% |
| Sep 30, 2022 | 8.24% |
| Jun 30, 2022 | 4.98% |
| Mar 31, 2022 | 10.72% |
| Dec 31, 2021 | 23.68% |
| Sep 30, 2021 | 25.89% |